Skip to main content

Table 2 Breast Cancer Related Cumulative Charges by BRCA Status and Charge Type

From: Estimation of healthcare‐related charges in women with BRCA mutations and breast cancer

Health care charges ($US)

Overall n=816

BRCAm n=134

BRCAwt n=682

BRCAm vs. BRCAwt

Mean

(SD)

Median (IQR)

Mean

(SD)

Median (IQR)

Mean

(SD)

Median (IQR)

p-value

Facilities/ Technical

29,090

(26,802)33.8%a

24,027

(34,043)

35,130

(28,878) 40.5%

33,037

(42,145)

27,903

(26,234)

32.5%

22,458

(32,529)

0.01

Physician/ Professional

15,615

(13,126), 18.2%

12,441

(17,669)

16,207

(12,198), 18.7%

15,624

(18,967)

15,498

(13,306)

18.1%

11,908

(16,906)

0.25

Pharmacy

41,277

(69,308)

48.0%

9,313

(58,716)

35,352

(51,919) 40.8%

11,379

(54,399)

42,442

(72,209)

49.4%

8,930

(59,659)

0.65

Total Anticancer

Treatment

24,616

(56,779)

2,018

(15,804)

16,821

(38,088)

2,756

(14,673)

26,148

(59,671)

1,824

(15,995)

0.72

 Other Medication(s)

16,661

(24,471)

2,911

(27,834)

18,531

(24,484)

6,035

(30,729)

16,294

(24,470)

2,609

(26,434)

0.19

 Clinical Trial

56

(347)

0

(0)

89

(621)

0

(0)

49

(262)

0

(0)

0.93

 Chemotherapy

7,171

(14,088)

1,372

(6,575)

8,439

(14,791)

2,344

(9,463)

6,922

(13,944)

1,180

(6,124)

0.13

 Hormonal Therapy

890

(5,521)

0

(0)

769

(4,334)

0

(0)

914

(5,728)

0

(0)

0.53

 Biologic Medicine

16,499

(50,091)

0

(0)

7,524

(30,898)

0

(0)

18,262

(52,891)

0

(0)

0.02

 Chemotherapy Administration

0

(5)

0

(0)

1

(7)

0

(0)

0

(5)

0

(0)

NA

Total Charges

85,982

(94,087)

55,230

(94,787)

86,689

(75,937)

65,414

(95,894)

85,843

(97,304)

54,635

(94,085)

0.19

  1. aPercent contribution of the charge type to total charges
  2. SD Standard deviation, IQR Interquartile range